GE Healthcare Exec Says PCS Growth In Q4 To Be Muted By Product Hold Comparison, Not Market Deceleration; Contrast Media Market Capacity Is Currently Maxed Out; Section 232 Tariffs Are Biggest Uncertainty For 2027; Moved Certain Systems, Components To Other Countries To Help Offset Tariff Impact; Says Majority Of Q4 Revenue Already Backed By Orders In Hand

뉴스 본문을 불러오고 있어요.

GE Healthcare Exec Says PCS Growth In Q4 To Be Muted By Product Hold Comparison, Not Market Deceleration; Contrast Media Market Capacity Is Currently Maxed Out; Section 232 Tariffs Are Biggest Uncertainty For 2027; Moved Certain Systems, Components To Other Countries To Help Offset Tariff Impact; Says Majority Of Q4 Revenue Already Backed By Orders In Hand | 웨이프 WAPE

기사 요약

관련 종목

댓글 —